# Blood based multi biomarker panel discriminates Alzheimer disease from healthy controls in a single center nested cross validation

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41598-026-79195-6) · 2026-11-11 · Life
Page: https://themorning.science/story/blood-based-multi-biomarker-panel-discriminates-alzheimer-disease-from-healthy-c-3edb44ba6218e284
Kind: research · Impact: low

## In brief

- A blood-based multi-biomarker panel was tested for distinguishing Alzheimer disease from healthy controls.
- The evaluation used a single-center nested cross-validation design.
- The source provides only the title and feed listing, so no performance figures are available here.

## Why it matters

Blood-based biomarkers could eventually offer a less invasive way to screen for Alzheimer disease, but results from one center under cross-validation still need independent validation before clinical use.

## Timeline

- 2026-11-11: Article listed in nature.com biological sciences subject feed

## Coverage

- [Blood based multi biomarker panel discriminates Alzheimer disease from healthy controls in a single center nested cross validation](https://www.nature.com/articles/s41598-026-79195-6) — Biological sciences : nature.com subject feeds, 2026-11-11

Tags: alzheimer, biomarkers, blood test, diagnostics, cross-validation

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science